About us > Madeline Miceli, MD

Madeline Miceli, MD

Madeline Miceli

Highlights

  • Hematology and medical oncology fellow and clinical researcher
featured_paragraph

Madeline Miceli, MD, is a hematology and medical oncology fellow and clinical researcher whose work focuses on the care of people living with breast cancer. Her research interests include monitoring tumors using genome-based biomarkers and studying both new and standard therapies, as well as treatment combinations, to advance the field of breast oncology. She received her medical degree from New York Medical College.

contributions_carousel

Contributions

Cyclophosphamide

06/14/26 | BY: Madeline Miceli

Cyclophosphamide (Cytoxan) is a type of chemotherapy medicine used to treat early-stage and metastatic breast cancer. It belongs to a group of chemotherapy medicines called alkylating agents.

Read More
 | 3 Min. Read

Docetaxel

06/14/26 | BY: Madeline Miceli

Docetaxel (Taxotere) is a type of chemotherapy that treats all stages of breast cancer. It belongs to a class of chemotherapy medicines called taxanes, and can be used in combination with other treatments.

Read More
 | 3 Min. Read

Doxorubicin

06/14/26 | BY: Madeline Miceli

Doxorubicin (Adriamycin) is a type of anthracycline chemotherapy. This medicine is part of a class of chemotherapy drugs called anthracyclines.

Read More
 | 3 Min. Read